These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22044671)

  • 1. A single administration of the GnRH antagonist acyline inhibits basal and GnRH-stimulated serum testosterone concentrations in male dogs.
    García Romero G; Mattioli G; Rosa D; Diaz JD; Abeyá M; Gobello C
    Reprod Domest Anim; 2012 Jun; 47(3):e32-5. PubMed ID: 22044671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine effects of the GnRH antagonist, acyline, in domestic dogs.
    García Romero G; Valiente C; Aquilano D; Corrada Y; Gobello C
    Theriogenology; 2009 May; 71(8):1234-7. PubMed ID: 19193431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a GnRH antagonist on GnRH agonist-implanted anestrous bitches.
    Valiente C; Diaz JD; Rosa DE; Mattioli G; García Romero G; Gobello C
    Theriogenology; 2009 Oct; 72(7):926-9. PubMed ID: 19608263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two doses of the GnRH antagonist, acyline, for pregnancy termination in bitches.
    Valiente C; Corrada Y; de la Sota PE; Blanco PG; Arias D; Gobello C
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():156-9. PubMed ID: 19754557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of the canine estrous cycle with a low and a high dose of the GnRH antagonist, acyline.
    Valiente C; Romero GG; Corrada Y; de la Sota PE; Hermo G; Gobello C
    Theriogenology; 2009 Feb; 71(3):408-11. PubMed ID: 18789519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic gonadotropin-releasing hormone agonist treatment on serum luteinizing hormone and testosterone concentrations in boars.
    Almond GW; Esbenshade KL; Smith CA; Richards RG
    Am J Vet Res; 1992 Jan; 53(1):22-5. PubMed ID: 1531744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible downregulation of the hypothalamic-pituitary-gonadal axis in stallions with a novel GnRH antagonist.
    Davolli GM; Ball BA; Esteller-Vico A; Claes AN; Canisso IF; Fedorka CE; Woodward EM; Troedsson MH; Squires EL
    Theriogenology; 2016 Dec; 86(9):2272-2280. PubMed ID: 27570103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.
    Herbst KL; Coviello AD; Page S; Amory JK; Anawalt BD; Bremner WJ
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5959-65. PubMed ID: 15579744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gonadotropin-releasing hormone administration on the pituitary-gonadal axis in male and female dogs before and after gonadectomy.
    de Gier J; Buijtels JJ; Albers-Wolthers CH; Oei CH; Kooistra HS; Okkens AC
    Theriogenology; 2012 Mar; 77(5):967-78. PubMed ID: 22153274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative response of rams and bulls to long-term treatment with gonadotropin-releasing hormone analogs.
    Jiménez-Severiano H; D'Occhio MJ; Lunstra DD; Mussard ML; Davis TL; Enright WJ; Kinder JE
    Anim Reprod Sci; 2007 Apr; 98(3-4):204-24. PubMed ID: 16616998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat.
    Goericke-Pesch S; Georgiev P; Fasulkov I; Vodenicharov A; Wehrend A
    Theriogenology; 2013 Jul; 80(1):65-9. PubMed ID: 23622940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.
    Purswell BJ; Wilcke JR
    J Reprod Fertil Suppl; 1993; 47():335-41. PubMed ID: 8229946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse model of male germ cell apoptosis in response to a lack of hormonal stimulation.
    Hikim AP; Vera Y; Elhag RI; Lue Y; Cui YG; Pope V; Leung A; Atienza V; Wang C; Swerdloff RS
    Indian J Exp Biol; 2005 Nov; 43(11):1048-57. PubMed ID: 16315394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the koala (Phascolarctos cinereus) anterior pituitary-gonadal axis with analogues of GnRH.
    Allen CD; Burridge M; Chafer ML; Nicolson VN; Jago SC; Booth RJ; Fraser G; Ensabella TJ; Zee YP; Lundie-Jenkins G; Holt WV; Lisle AT; Carrick FN; Curlewis JD; D'Occhio MJ; Johnston SD
    Reprod Fertil Dev; 2008; 20(5):598-605. PubMed ID: 18577357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone.
    Hild SA; Attardi BJ; Reel JR
    Biol Reprod; 2004 Jul; 71(1):348-58. PubMed ID: 15044265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
    Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
    J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the GnRH antagonist, acyline, on canine testicular characteristics.
    Valiente C; Corrada Y; de la Sota PE; Gerez PG; Gobello C
    Theriogenology; 2007 Sep; 68(5):687-92. PubMed ID: 17586037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GnRH antagonists vs agonists in domestic carnivores, a review.
    Gobello C
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():373-6. PubMed ID: 23279542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged pulsatile administration of gonadotrophin-releasing hormone (GnRH) to fertile stallions.
    Roser JF; Hughes JP
    J Reprod Fertil Suppl; 1991; 44():155-68. PubMed ID: 1665513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.